Article
September 5, 2024
A new study supported by Transparency International Global Health examines the progress of procurement transparency reforms in nine low- and middle-income countries across Africa and Asia. The research, published in the Governance journal, is an in-depth analysis of efforts to improve legal frameworks and open access to data in government contracting between 2008 and...
Join us on Wednesday 12 June, 15: 00 CET/ 09:00 EST for the first webinar in the 2024 series from Transparency International Global Health, in partnership with USAID and the World Health Organization’s Global Network for Anti-corruption, Transparency and Accountability in Health (GNACTA). With our expert panel, we will explore what forms state capture...
Reflecting on 2023, we marked a significant year in our journey towards the Sustainable Development Goals, set for 2030. ‘Health for All’ (Goal 3) remains a pivotal commitment, undertaken by United Nations member states in 2015. Despite advances, challenges such as corruption continue to hinder progress. We continue our commitment with upcoming events covering...
Jonathan Cushing, Programme Director, TI Global Health Programme When Victoria Amponsah sought treatment for malaria she thought that she would quickly recover once she got the medicine prescribed to her from the pharmacy. But she didn’t. Her condition worsened and she ended up hospitalised. She later learned that the pills she had been prescribed were...
Statement
September 8, 2023
Responding to the COVID-19 ‘secrets contracts’ court verdict in South Africa, Jonathan Cushing, Director of Transparency International Global Health, said: Transparency International Global Health congratulates South Africa’s Health Justice Initiative on its recent legal success in its campaign to secure the release of COVID-19 vaccine contracts. The South African contracts show the arduous steps, along...
Reducing the cost of medicines is a crucial step in improving healthcare access and outcomes. The logic is straightforward: savings on pharmaceuticals can be reinvested in more medicines or improved services, leading to a healthier global population. With pharmaceutical expenditure constituting a significant portion of healthcare budgets and playing a pivotal role in shaping health...
